Efficacy and safety of ledipasvir/sofosbuvir (LDV /SOF ) with or without ribavirin for the treatment of chronic hepatitis C patients with advanced liver disease
Latest Information Update: 12 Aug 2020
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C; Liver disorders
- Focus Adverse reactions; Therapeutic Use
- 12 Aug 2020 New trial record